← Leaderboards
Eli Giboa
Duke University
$172,536
Attributed
$172,536
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$172,536 · 1
By mechanism
P01$172,536 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Herbert Kim Lyerly$48,598,090
- Victoria L. Seewaldt$17,302,500
- Mikhail Nikiforov$14,564,827
- Darell D Bigner$25,397,506
- Daniel J Lew$23,675,308
Others in their field
Top investigators on “Antigen Presenting Cell”
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Ellis L Reinherz · Dana-Farber Cancer Institute$37,262,008
- Emil R Unanue · Washington University$29,036,066
- Mitchell Kronenberg · Cedars-Sinai Medical Center$28,767,078
- Donald L Morton · John Wayne Cancer Institute$27,764,680
Research focus
Antigen Presenting CellCarcinoembryonal AntigenColorectal NeoplasmsCytotoxic T LymphocyteDendritic CellsDisease /Disorder ModelLaboratory MouseMessenger RnaMetastasisMethod DevelopmentNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer VaccineNeoplastic CellNonhuman Therapy EvaluationPolymerase Chain ReactionSubtraction HybridizationTumor AntigensVaccine Development
Grant awards (3)
PRECLINICAL STUDIES OF TOTAL TUMOR RNA TRANSFECTED DENDRITIC CELL IMMUNOTHERAPY$86,268
P01 · FY2002 · CA
PRECLINICAL STUDIES OF TOTAL TUMOR RNA TRANSFECTED DENDRITIC CELL IMMUNOTHERAPY$86,268
P01 · FY2001 · CA
PRECLINICAL STUDIES OF TOTAL TUMOR RNA TRANSFECTED DENDRITIC CELL IMMUNOTHERAPY$0
P01 · FY2000 · CA